| Literature DB >> 34203720 |
Imane Zalegh1,2, Mohamed Akssira2, Mohammed Bourhia3, Fouad Mellouki1, Naima Rhallabi1, Ahmad Mohammad Salamatullah4, Mohammed Saeed Alkaltham4, Heba Khalil Alyahya4, Rajaa Ait Mhand1.
Abstract
Resistance to drugs is reaching alarming levels and is placing human health at risk. With the lack of new antimicrobials drugs, infectious diseases are becoming harder to treat. Hence, there is an increasing awareness of active phytochemicals with therapeutic functions. The tremendous research interest on the Cistus L. genus includes numerous plants used in traditional medicine by people living around the Mediterranean Sea, also resulted in some interesting discoveries and written literature. This review aimed at gathering scientific literature about Cistus species, describing phytochemical profiles and the various pharmacological activities. We also extensively reviewed the antimicrobial activities, including antiviral, antiparasitic, antifungal, and antibacterial potentials of Essential Oils (EO), raw extracts as well as isolated compounds. Mechanisms of action along with methods used are also investigated in this review. Considering the findings of the Cistus species extracts, this genus offers an adequate reserve of active phytochemicals since many have been used to create drugs. Therefore, this review work can serve society by providing a global view on Cistus L. sp. regarding pharmacological potentials and their chemical profiles.Entities:
Keywords: Cistus sp.; antimicrobials; microorganisms; multidrug resistance; phytochemicals
Year: 2021 PMID: 34203720 PMCID: PMC8232106 DOI: 10.3390/plants10061214
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Antiviral potent of Cistus extracts.
| Collection Area | Part | Type of | Viruses | Technique | Concentration µg/mL | % of Inhibition | Mechanism | References | |
|---|---|---|---|---|---|---|---|---|---|
|
| Northern Greece | ND | CYSTUS052 solved | H7N7 | Cell culture and | 10,000 | 90% | Binding with virus and prevent adsorption to cells | [ |
|
| Northern Greece | ND | CYSTUS052 solved | H1N1 | Cell culture and plaque titration of progeny virus | 50 | Maximum reduction | Interaction of CYSTUS052 components with viral protein surface and block binding to cellular receptors | [ |
| Northern Greece | ND | Aqueous extract | HIV | Cell culture and EASY-HIT technology for identification of HIV | 100 | More than 80% | Blocking the viral gp120-mediated binding of virus protein to heparin and prevent primary attachment to host cells | [ | |
|
| Kurtboğazı, Ankara, | Leaves | Ethanolic | HSV-1 | Cell culture and Maximum cytopathogenic | 512 | Not determined most | ND | [ |
|
| Northern | Labdanum resin | Diethyl ether | Dengue virus | Cell culture and MTT-test | 31.25 | 100% | Based on literature: neuraminidase inhabiting and blocking viral proteins to prevent infection of host cells | [ |
ND: Not determined; H7N7: Avian influenza virus A/FPV/Bratislava/79; H1N1: Human influenza virus A/Puerto Rico/8/34; H5N1: Human influenza isolate A/Thailand/1(KAN-1)/2004; HIV: Human immunodeficiency virus; HSV-1: Human alphaherpesvirus 1; PI-3:Parainfluenza type 3.
Antiparasitic potent of Cistus extracts.
| Collection Area | Part of Plant | Type of Extract | Parasite | Technique | Concentration µg/mL | IC50 | Mechanism | References | |
|---|---|---|---|---|---|---|---|---|---|
|
| Greece | Aerial parts | Pure compounds from Dichloromethane extracts and semisynthetic derivatives |
| In vitro culture of promastigote and Alamar blue assay | 1.6–8–40 | From 3.5 to 37 | ND | [ |
|
| Ouezzane, Morocco | Leaves | Methanolic, |
| MTT assay | ND | ND | [ |
ND: Not determined; L: Leishmania.
Antifungal potent of Cistus extracts.
| Collection Area | Part of Plant | Type of Extract | Fungi | MIC µg/mL | MGI % | References | |
|---|---|---|---|---|---|---|---|
|
| Greece | Leaves | EO |
| MID (1/250) | ND | [ |
| Kandanos | Aerial parts | EO |
| MID (<1/200) | ND | [ | |
| MID (<1/250) | |||||||
|
| ND | ND | Essential Oil; |
| 4000 to 10,000 ppm | 99.4% | [ |
|
| Ourika, | Leaves | Methanolic extracts |
| 100,000 to 200,000 | ND | [ |
|
|
| 25,000 to 200,000 | |||||
|
| Agadir, | Leaves+stem | Plant powders |
| ND | 100% | [ |
| EO | 37% | ||||||
| Methanolic | 77% | ||||||
| Chloroformic | 27% | ||||||
|
| Agadir, | Leaves and stem | Aqueous |
| 156 | 100% | [ |
|
| Montesinho, | Leaves | Phenolic extract |
| <50 | ND | [ |
|
| Greece | ND | Hydro-methanolic |
| ND | 45.91% | [ |
|
| Turkey | Unknown | Aqueous |
| 32,000 | ND | [ |
|
| Morocco | Aerial parts | Aqueous |
| >10,000 | >80% | [ |
|
| Aerial parts | 1250 | 100% | ||||
|
| Aerial parts | <625 | 100% | ||||
|
| Aerial parts | <625 | ND | ||||
|
| Aerial parts | <625 | 100% | ||||
|
| Aerial parts | <625 | 100% | ||||
|
| Aerial parts | >10,000 | 100% | ||||
|
| Leaves | <625 | 100% | ||||
|
| Tafraout, | Leaves | EO |
| 1/64 | ND | [ |
| Ethanolic | >10,000 | ||||||
|
| Jendouba, | Leaves | Ethanol |
| ND | 6300–12,500 | [ |
ND: Not determined; C. albicans: Candida albicans; A. niger: Aspergillus niger; B. cinerea: Botrytis cinerea; M. racemosus: Mucor racemosus: Verticilliumalbo-atrum; A. fumigatus: Aspergillus fumigatus; C. krusei: Candida krusei; C. glabrata: Candida glabrata; P. digitatum: Penicillium digitatum; P. italicum: Penicillium italicum; G. candidum: Geotrichum candidum; C. tropicalis: Candida tropicalis; C. parapsilosis: Candida parapsilosis; A. parasiticus: Aspergillus parasiticus; A. carbonarius: Aspergillus carbonarius; C. versicolor: Coriolus versicolor; G. trabeum: Gloeophyllum trabeum; C. puteana: Coniophora puteana; P. placenta: Poria placenta; P. digitatum: Penicillium digitatum; P. expansum: Penicillium expansum.
Antifungal and antiaflatoxigenic potent of Cistus extracts.
| Collection Area | Part of Plant | Type of Extract | Fungi | Fungi Secondary Metabolites | MIC µL/mL | Finding | Mode of Action | References | |
|---|---|---|---|---|---|---|---|---|---|
|
| North Greece | ND | Hydro-methanolic |
| Aflatoxin B1 | ND | Both mediums (macadamia, YES) inoculated in the presence of | ND | [ |
|
| ND | ND | Essential Oil | Aflatoxin B1 | 0.6 | The EO was found to have an intense antifungal activity, with fungistatic | Inhibition of ergosterol biosynthesis and enhancement of ions leakage from fungal cells leads to fungal growth inhibition | [ |
Antibacterial potential of the essential oils of Cistus.
| Collection Area | Part of Plant | Type of Extract | Tested Bacteria | DZI (mm) | MID | References | |
|---|---|---|---|---|---|---|---|
|
| Greece | Leaves | EO |
| ND | 1/2000 | [ |
|
| Kandanos, Chania, Greece | Aerial parts | EO |
| ND | <1/2000 | [ |
|
| Greece | Resin Ladano | EO |
| ND | 2000 µg/mL | [ |
|
| Corsica, France | Aerial parts | EO |
| 52 | 800 µg/mL | [ |
| Hydrocarbonated fraction | 6.70 | 50,000 µg/mL | |||||
| Oxygenated fraction | 35 | 100 µg/mL | |||||
| Acetate fraction | 30 | 12.5 µg/mL | |||||
| Alcohol fraction | 50 | 1500 µg/mL | |||||
|
| Alentejo, Portugal | Leaves | EO |
| 11 | ND | [ |
|
| Unknown | Leaves | EO |
| ND | 400 | [ |
MID: Maximum Inhibitory Dilution; ND: Not determined; S. aureus: Staphylococcus aureus; S. epidermidis: Staphylococcus epidermidis; E. coli: Escherichia coli; P. aeruginosa: Pseudomonas aeruginosa; B. subtilis: Bacillus subtilis; M. luteus: Micrococcusluteus; S. hominis: Staphylococcus hominis; S. pneumonia: Streptococcus pneumonia; MRSA: Methicillin-resistant Staphylococcus aureus; E. coli ESBL: Escherichia coli Extended Spectrum β-lactamases.
Antibacterial potent of isolated compounds of Cistus.
| Cistus Species | Collection Area | Part of Plant | Isolated Compounds | Tested Bacteria | MIC (µg/mL) | References |
|---|---|---|---|---|---|---|
|
| Greece | Resin Ladano |
| 100 | [ | |
|
| ND | Leaves |
|
| 31 | [ |
|
| Turkey | Aerial parts | Apigenin |
| ND | [ |
ND: Not determined; MIC: Minimum Inhibitory Concentration; S. aureus: Staphylococcus aureus; S. epidermidis: Staphylococcus epidermidis; S. hominis: Staphylococcus hominis; K. pneumoniae: Klebsiellapneumoniae; E. coli: Escherichia coli; P. aeruginosa: Pseudomonas aeruginosa; B. subtilis: Bacillus subtilis; A. fischeri: Aliivibrio fischeri; *: The antibacterial assay in this study was performed using Thin-layer chromatography-direct bioautography.
Antibacterial potent of crude extracts of Cistus.
| Collection | Part of | Solvent Used | Sensitive | DZI (mm) | MIC | References | |
|---|---|---|---|---|---|---|---|
| Aegean Mediterranean | Leavesand fruits | Water |
| 9–15 | ND | [ | |
|
| Ourika, Marrakesh, Morocco | Leaves | Methanol |
| ND | 1560–3125 | [ |
|
| 3125–25,000 | ||||||
|
| Chefchaouen, Morocco | Leaves | Water |
| Total inhibition at | [ | |
|
| Tunisia | Leaves and Flowers | Hexane |
| 12–23 | 156–625 | [ |
|
| Spain | Aerial parts | Water |
| ND | MIC50 154 | [ |
|
| 344 | ||||||
|
| Unknown | Leaves | Ethanol |
| 20 | 515 | [ |
|
| Spain | Unknown | Water |
| ND | MIC50 144–569 | [ |
|
| 60–292 | ||||||
|
| 45–52 | ||||||
|
| 91–392 | ||||||
|
| Ouezzane, Morocco | Leaves | Ethanol |
| 9 | ND | [ |
|
| Aerial parts | 9 | |||||
|
| Ouezzane, Morocco | Leaves | Ethanol |
| <8–14 | >8000 | [ |
|
| 15–29 | 1000–3000 | |||||
|
| 21–31 | 1000–8000 | |||||
|
| <8–13 | 1000–>8000 | |||||
|
| Turkey | Unknown | Water |
| ND | 500 | [ |
|
| Ankara, Turkey | Leaves | Ethanol |
| ND | 32 | [ |
|
| Leaves | Methanol |
| 13 | 64 | [ | |
|
| Taza, Morocco | Leaves | Ethanol |
| ND | 2500 | [ |
|
| Sidi Mechreg, Tunisia | Leavesand Flowers | Ethanol |
| 22–24 | 12,500 | [ |
|
| 11–22 | 12,500 | |||||
|
| Jendouba, | Leaves | Ethanol |
| 18 | 12,500 | [ |
|
| 14 | 6300 |
ND: Not determined; DZI: Diameter of Zone Inhibition; MIC: Minimum Inhibitory Concentration; S. aureus: Staphylococcus aureus; B. subtilis: Bacillus subtilis; B. cereus: Bacillus cereus; E. coli: Escherichia coli; P. aeruginosa: Pseudomonas aeruginosa; E. hirea: Enterococcus hirea; M. aurum A: Mycobacterium aurum A; M. smegmatis MC: Mycobacterium smegmatis MC; M. bovis: Mycobacterium bovis; M. vaccae: Mycobacterium vaccae; S. epidermidis: Staphylococcus epidermidis; S. saprophyticus: Staphylococcus saprophyticus; E. faecalis: Enterococcus faecalis; L. monocytogenes: Listeria monocytogenes; MRSA: Methicillin-resistant Staphylococcus aureus; MRSE: Methicillin-resistant Staphylococcus epidermidis; S. pyogenes β: Streptococcus pyogenes; E. hirae: Enterococcus hirae; H. pylori: Helicobacter pylori; P. mirabilis: Proteus mirabilis; K. pneumoniae: Klebsiella pneumoniae; A. baumannii: Acinetobacter baumannii; E. aerogenes: Enterobacter aerogenes; P. stuartii: Providencia stuartii; S. typhimirium: Salmonella typhimirium.
Antibiofilm potent of Cistus extract.
| Collection Area | Part of Plant | Solvent Used | Bacteria Used | Surface Used | Finding | References | |
|---|---|---|---|---|---|---|---|
| Northern Greece | Unknown | Water | Oral bacteria | Cylindrical | Rinses with | [ | |
|
| Taza, Morocco | Leaves | Ethanol |
| 304 L SS coupons | [ |
P. aeruginosa: Pseudomonas aeruginosa.